Search clinical trials for: Avelumab Phase 1b

Total 1793 results

Bayer

Completed

BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up Study

Multiple Sclerosis

Belgium, Italy, Spain, France, Germany, Canada, Switzerland, Austria, Denmark, Hungary, Netherlands, Poland, Israel, United Kingdom, Finland, Sweden, Norway, Czech Republic, Portugal, Slovenia
Pfizer

Completed

A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)

Renal Cell Cancer

United States, United Kingdom, Japan
Centre Francois Baclesse
Pfizer

Recruiting

TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma (TALASUR)

Urothelial Carcinoma

France
Andrew Sharabi
Pfizer

Terminated

Stereotactic Body Radiation Therapy (SBRT) Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)

Early Stage Non-Small Cell Lung Cancer

United States
Seoul National University Hospital
Merck KGaA, Darmstadt, Germany

Completed

Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib Treatment (AvelumabHCC)

Carcinoma, Hepatocellular

Korea, Republic of
Assuntina Sacco, M.D.
Pfizer

Terminated

Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer

Nasopharyngeal Cancer

United States
Effector Therapeutics
Pfizer; Merck KGaA, Darmstadt, Germany

Completed

A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer

Microsatellite Stable Relapsed or Refractory Colorectal Cancer

United States
National Cancer Institute, Slovakia
Merck KGaA, Darmstadt, Germany

Completed

Avelumab in Refractory Testicular Germ Cell Cancer.

Neoplasms | Gonadal Disorders | Neoplasms, Germ Cell and Embryonal | Testicular Neoplasms | Testicular Diseases | Antineoplastic Agents | Molecular Mechanisms of Pharmacological Action

Slovakia
Institut Universitari Dexeus

Completed

Luteal Phase-start Ovarian Stimulation With Corifollitropin Alfa

Infertility

Spain
Pfenex, Inc

Completed

Comparison Study of PF530 and Betaferon in Healthy Subjects

Multiple Sclerosis

Australia
Bayer

Completed

Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients

Multiple Sclerosis

France
Bayer

Completed

Injection Management With Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH)

Relapsing-Remitting Multiple Sclerosis

Germany
University of Arizona
National Institute on Deafness and Other Communication Disorders (NIDCD)

Not yet recruiting

Addressing Treatment Nonresponders

Language Development Disorders
University of Colorado, Denver
Kaiser Permanente

Completed

Integrating Palliative Care Social Workers Into Sub-Acute Settings: A Feasibility Trial (ALIGN)

Advanced Medical Illness

United States
Leiden University Medical Center
VU University of Amsterdam; Universiteit Leiden

Completed

Electrophysiological Correlates of Nocebo Effects on Pain

Chronic Pain | Hyperalgesia | Chronic Pain Syndrome | Chronic Pain, Psychogenic

Netherlands
Assistance Publique - Hôpitaux de Paris
URC-CIC Paris Descartes Necker Cochin; MICALIS Institute

Recruiting

Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Crohn's Disease Patients. (ASCENSION)

Crohn's Disease

France
Pfizer
Merck KGaA, Darmstadt, Germany

Active, not recruiting

A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (AVENANCE)

Urothelial Carcinoma

France
Pfizer

Terminated

A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer

Bladder Cancer

Brazil, Argentina
Sunnybrook Health Sciences Centre
Merck KGaA, Darmstadt, Germany

Completed

Avelumab in G3 NEC (NET-001)

Neuroendocrine Carcinoma

Canada
Merck KGaA, Darmstadt, Germany
Pfizer

Approved for marketing

Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC)

Metastatic Merkel Cell Carcinoma

France
H. Lee Moffitt Cancer Center and Research Institute
James and Esther King Biomedical Research Program; Bankhead-Coley Florida Biomedical...

Completed

Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer

Adenocarcinoma | Lung Cancer

United States
Bayer

Completed

Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis (CogniPlus)

Multiple Sclerosis

Turkey, Czechia, Hungary, Israel, Germany, France, Belgium, Greece, Netherlands, Egypt, Kazakhstan, Argentina, Portugal, Algeria, Saudi Arabia, Albania, Tunisia
Bayer

Completed

Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE) (INFLUENCE)

Multiple Sclerosis

Poland
Bayer

Completed

Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis

Multiple Sclerosis

China
Bayer

Withdrawn

Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)

Multiple Sclerosis

Sweden, Denmark
Bayer

Completed

Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting

United States
Bayer

Completed

Betaferon/ Betaseron (Interferon Beta-1b) in Patients With Chronic Viral Cardiomyopathy

Heart Diseases | Cardiomyopathies

Italy, Spain, Germany, Poland, United Kingdom, Sweden, France
Pfizer

Terminated

Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies

Non-small Cell Lung Cancer | Urothelial Cancer

Spain, Czechia, United States, Australia, United Kingdom, Italy, Canada, Hungary
Institute of Tropical Medicine, Belgium
SRI International; Sihanouk Hospital Center of HOPE

Completed

Study to Obtain Blood and Voided Urine Samples to Improve the Diagnosis of Melioidosis

Systemic Inflammatory Response Syndrome | Melioidosis | Suspected or Confirmed Bloodstream Infections

Cambodia
3D Medicines

Not yet recruiting

3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain

Cancer Pain
Ruijin Hospital

Recruiting

Simultaneous Integrated Boost for Mediastinal Lymph Node Recurrence After Radical Surgery of Esophageal Cancer

Esophageal Cancer | Salvage Radiotherapy | Dose-escalation | Mediastinal Lymph Node Recurrence

China
Eli Lilly and Company

Completed

Notch Inhibitor in Advanced Cancer

Advanced Cancer

United States
US Department of Veterans Affairs

Completed

Effect of a High Protein Diet on the 24-hour Profile of Ghrelin, GH (Growth Hormone) and IGF-1 (Insulin-like Growth Factor-1)

Diabetes Mellitus, Type 2

United States
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...

Completed

Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2)

Renal Cell Carcinoma

Japan
UNC Lineberger Comprehensive Cancer Center

Completed

Visibility of Lesion Characteristics With Phase Contrast Mammography

Breast Cancer

United States
Fred Hutchinson Cancer Center
National Institute on Drug Abuse (NIDA)

Withdrawn

Adaptive Treatment Strategies for Improving Engagement With a Web-Based Smoking Intervention in Socially Anxious Smokers

Tobacco Use Disorder | Social Anxiety Disorder

United States
Belén Retamal-Valdes

Unknown

Amoxicillin and Metronidazole During Periodontal Treatment (MOMENT)

Chronic Periodontitis

Brazil
Riphah International University

Recruiting

Effects of Mindfulness Based Therapy on Illness and Depression in Cardiac Rehab Phase-i

Coronary Artery Stenosis

Pakistan
Centre hospitalier de l'Université de Montréal...
Canadian Institutes of Health Research (CIHR); Centre de Recherche du Centre...

Completed

DCE-MRI for Assessment of Response to TACE of HCC (DCE-MRI)

Carcinoma, Hepatocellular

Canada
Parc de Salut Mar

Completed

A Comparative Study of Two Patterns of Controlled Ovarian Hyperstimulation in Mid Follicular Phase or Early Luteal Phase for Egg Donors

Stimulation in the Ovary

Spain
University of Alabama at Birmingham
University of Colorado, Denver; National Institute on Aging (NIA); University...

Recruiting

Effect of High-Intensity Exercise to Attenuate Cognitive Function Limitations and Train Exercise Habits in Older People Living With HIV (HEALTH-COG)

HIV Infections | Cognitive Impairment

United States
Sunnybrook Health Sciences Centre

Recruiting

UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3) (UNITED-3)

Glioblastoma Multiforme, Adult

Canada
Ant Shepherd
Hampshire Hospitals NHS Foundation Trust

Unknown

The Impact of Covid-19 on Cardiac Rehabilitation Participants and Staff

Heart Diseases
Rigshospitalet, Denmark
Odense University Hospital

Completed

SheppHeartCABG - Phase One Rehabilitation After Coronary Artery Bypass Grafting (SheppHeart)

Ischaemic Heart Disease

Denmark
US Department of Veterans Affairs

Completed

Respiratory-Swallow Training in Veterans With Oropharyngeal Cancer (RSPT)

Oropharyngeal Dysphagia | Oropharyngeal Cancer

United States
Pfizer

Terminated

A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)

Non-Small Cell Lung Cancer | Urothelial Cancer

Korea, Republic of, United States, Taiwan, Poland, Spain, Russian Federation, Italy, Hungary
Bayer

Completed

China Betaferon Adherence, Coping and Nurse Support Study

Multiple Sclerosis, Chronic Progressive

China
Bayer

Completed

Prospective, Multicenter Non Interventional Study to Evaluate Adherence to Betaferon Over a 2 Years Period (SEPLUS)

Multiple Sclerosis

France
Rutgers, The State University of New Jersey
Bayer

Completed

Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis

Multiple Sclerosis

United States
Bayer

Completed

Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis (BREAK)

Multiple Sclerosis

Poland

Search clinical trials for: Avelumab Phase 1b

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations